MoneyWorks4Me

Smruthi Organics - Quaterly Results

05 May 2025 Evaluate
Revenue reduced marginally to stand at Rs. 380.94 millions during the quarter ended March 2025. The figure stood at Rs. 396.58 millions during the year-ago period.A comparatively good net profit growth of 46.71% to Rs. 22.30 millions was reported for the quarter ended March 2025 compared to Rs. 15.20 millions of previous same quarter.The company reported a good operating profit of 47.55 millions compared to 41.46 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 380.94 396.58 -3.94 1260.08 1276.43 -1.28 1260.08 1276.43 -1.28
Other Income 0.76 0.61 24.59 0.89 0.76 17.11 0.89 0.76 17.11
PBIDT 47.55 41.46 14.69 122.71 120.31 1.99 122.71 120.31 1.99
Interest 5.16 3.72 38.71 18.70 14.08 32.81 18.70 14.08 32.81
PBDT 42.39 37.74 12.32 104.01 106.23 -2.09 104.01 106.23 -2.09
Depreciation 15.04 15.87 -5.23 55.01 56.53 -2.69 55.01 56.53 -2.69
PBT 27.35 21.87 25.06 49.00 49.70 -1.41 49.00 49.70 -1.41
TAX 5.05 6.67 -24.29 13.37 13.79 -3.05 13.37 13.79 -3.05
Deferred Tax 0.19 0.00 0.00 -0.32 -2.27 -85.90 -0.32 -2.27 -85.90
PAT 22.30 15.20 46.71 35.63 35.91 -0.78 35.63 35.91 -0.78
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 12.48 10.45 19.40 9.74 9.43 3.32 9.74 9.43 3.32
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..